Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
复方杜仲扶正合剂 (Compound Eucommia Fuzheng Mixture) is a traditional Chinese medicine (TCM) developed and manufactured by Guiyang Dechangxiang Pharmaceutical. It is an approved oral liquid formulation designed to tonify the liver and kidney, strengthen bones and muscles, and support the body's vital energy (Fuzheng). The mixture typically contains a combination of herbal extracts, including *Eucommia ulmoides* (Duzhong), *Astragalus* (Huangqi), *Lycium chinense* (Gouqizi), and *Epimedium* (Yinyanghuo). It is primarily indicated for patients suffering from symptoms associated with liver and kidney deficiency, such as chronic soreness and weakness in the waist and knees, dizziness, and general fatigue. As a complex herbal formulation, it works through multiple active compounds to modulate immune function and improve physical stamina.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 复方杜仲扶正合剂.